Biote Appoints Ross W. McQuivey, M.D. as Chief Medical Officer
Innovative physician leader brings over 20 years of experience to Biote’s executive team IRVING, Texas--(BUSINESS WIRE)--biote Corp. (“Biote” or the...
Day: June 16, 2022
Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic
Innovation Passport Awarded to Molgramostim for the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP), a Rare Lung Disease The Innovation...
Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System
The long-term implantable E3 CGM system now approved for commercialization in select European markets GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE...
Encision Reports Fourth Quarter Fiscal Year 2022 Results
BOULDER, CO / ACCESSWIRE / June 16, 2022 / Encision Inc. (OTCPK:ECIA), a medical device company owning patented Active Electrode...
Biophytis Presents Preclinical Efficacy Data for Sarconeos (BIO101) in Spinal Muscular Atrophy (SMA), a Rare Neuromuscular Disease
PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / June 16, 2022 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis" or...
Angle PLC Announces Predicting Immunotherapy Response in SCLC
PARSORTIX SYSTEM DEMONSTRATES POTENTIAL IN PREDICTING IMMUNOTHERAPY RESPONSE IN SMALL CELL LUNG CANCERCTCs isolated by the Parsortix system can be...